$1 Trillion And Counting...
The stewards of India’s rising affluence have created a new record with the elite club of dollar billionaires surging to 185 with a cumulative net worth of $1.19 trillion.
pharmaceuticals
September 2024
April 2024
February 2024
January 2024
November 2023
September 2023
August 2023
January 2023
Contract Manufacturing: Pharma’s New Growth Pill
Domestic contract development and manufacturing organisations are raking it in, thanks to India’s emergence as a pharma R&D hub and China’s supply chain issues.
India's annual trade deficit widens to $17.49 bn in Jan
Overall trade deficit dipped 37.11% to $70.43 billion in April-January 2023-24 from $111.99 billion in the year-ago period.
States On ‘Trillion Dollar’ Mission
Top five states set their own targets to contribute to India’s ambitious economic growth plan.
PLI Powers Manufacturing
Production-linked incentives start making India self-reliant in key sectors.
Glenmark's anti-diabetic drug biosimilar claims to cut therapy cost by 70%
The drug is being marketed under the brand name ‘Lirafit’, following approval from the Drug Controller General of India.
Cipla stock tanks 8% after USFDA warning over issues at MP unit
Warning letter stresses data integrity issues at company embedded with product complaints and microbial contamination
Pharma's Richest Ride Demand Tailwinds
The stellar run continues post-Covid as promoters reap benefits of growth in India and new launches in key markets.
Launching products in India at the same time as FDA approvals: Bayer
Bayer Pharmaceuticals positions India as a key supplier of raw materials and R&D support for global production.
Budget 2023 may offer Research Linked Incentive scheme for Indian pharma
RLI is expected to provide an extra financial cushion, in addition to the existing R&D sops available to pharmaceutical and biotech companies operating in India.
